Advertisement
Screener

ANAVEX LIFE SCIENCES CORP. (AVXL) Lease Obligation Incurred

1.4 / 5 stars · 14/51 Roast Me

ANAVEX LIFE SCIENCES CORP. Lease Obligation Incurred

ANAVEX LIFE SCIENCES CORP. (AVXL) reported Lease Obligation Incurred of $25.10 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:CapitalLeaseObligationsIncurred · last filed 2023-08-08

  • ANAVEX LIFE SCIENCES CORP. lease obligation incurred for the quarter ending 2023-06-30 was $25.10K, a 19.45% increase year-over-year.
  • ANAVEX LIFE SCIENCES CORP. lease obligation incurred for the quarter ending 2023-03-31 was $30.07K, a 82.38% increase year-over-year.
  • ANAVEX LIFE SCIENCES CORP. lease obligation incurred for the quarter ending 2022-06-30 was $21.02K.
  • ANAVEX LIFE SCIENCES CORP. lease obligation incurred for the quarter ending 2022-03-31 was $16.49K.
Period endLease Obligation Incurred 3 monthLease Obligation Incurred 6 monthLease Obligation Incurred 9 month
2023-06-30$25.10K
10-Q · filed 2023-08-08
$55.17K
derived: sum of 2 quarters · filed 2023-08-08
$85.24K
10-Q · filed 2023-08-08
2023-03-31$30.07K
10-Q · filed 2023-05-09
$60.14K
10-Q · filed 2023-05-09
2022-06-30$21.02K
10-Q · filed 2023-08-08
$37.50K
derived: sum of 2 quarters · filed 2023-08-08
$42.35K
10-Q · filed 2023-08-08
2022-03-31$16.49K
10-Q · filed 2023-05-09
$21.33K
10-Q · filed 2023-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95